Federal Lawsuit Challenges Medicare's Unprecedented Move to Fund Unapproved Cannabis

Washington D.C., Saturday, 25 April 2026.
A landmark lawsuit challenges a new Medicare program that bypasses FDA safety reviews to distribute unapproved cannabis products, potentially reshaping federal healthcare and pharmaceutical regulations.